VisionGate to Use MathStar Chip in Cell Visualization Technology | GenomeWeb
NEW YORK (GenomeWeb News) – VisionGate will use semiconductor developer MathStar’s technology to develop a medical imaging solution for cellular characterization that would be used to scan cells in patients at risk of cancer, MathStar said today.
 
Under the agreement, VisionGate will use MathStar’s Arrix FPOA chip as the processing engine for its Cell-CT platform, which is entering investigational clinical trials, MathStar said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.